US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist

38.530
+0.780+2.07%

Close Feb 19 16:00 ET

38.530
0.0000.00%

Post 17:49 ET

2.30BMarket Cap14.06P/E (TTM)

Protagonist Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Protagonist Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 81.013M	--
--	2024/Q4	-- / 56.648M	--
--	2024/Q3	4.675M / 1.813M	--
--	2024/Q2	4.167M / 6.667M	--
--	2024/Q1	254.953M / 120.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 81.013M--

--2024/Q4-- / 56.648M--

--2024/Q34.675M / 1.813M--

--2024/Q24.167M / 6.667M--

--2024/Q1254.953M / 120.000M--

Unlock Free Earnings Estimates

Open Account

Protagonist Therapeutics Earnings Reports

Protagonist Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 22:36 ET

Protagonist Therapeutics | 8-K: Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 7, 2024 16:15 ET

Protagonist Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6, 2024 16:24 ET

Protagonist Therapeutics | 8-K: Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 6, 2024 07:13 ET